Pfizer’s Braftovi (encorafenib) regimen has been granted accelerated approval by the US Food and Drug Administration (FDA) to ...

As the world’s third largest pharmaceutical market, Japan accounted for approximately 6% of the $1.5tn in global ...

Is your medical education strategy reaching the right HCPs in the formats they prefer? Discover actionable insights to ...

If you are struggling to navigate the complexity of early commercialisation, rest assured, you are not alone. Clinical trial ...

Elevate your MedEd strategy with our 2025 toolkit! From AI-driven patient avatars to interactive augmented reality scenarios, ...

Merck & Co – known as MSD outside the US and Canada – will be gaining exclusive global rights to Hansoh Pharma’s preclinical GLP-1 candidate in a deal worth over $2bn. The agreement gives Merck a ...

AstraZeneca’s Tagrisso (osimertinib) has been approved by the European Commission (EC) to treat a new subset of lung cancer ...

Sanofi’s investigational Bruton’s tyrosine kinase (BTK) inhibitor tolebrutinib has been granted breakthrough therapy designation by the US Food and Drug Administration (FDA) as a treatment for adults ...

The European Medicines Agency’s human medicines committee has recommended Galderma’s nemolizumab to treat atopic dermatitis and prurigo nodularis in patients with moderate-to-severe cases of the skin ...

AbbVie has shared promising top-line results from a phase 3 study of its investigational Parkinson’s disease (PD) candidate tavapadon in adults and said it is “on track” to submit a new drug ...

AI is shooting for the moon and the stars but the real benefits come from anchoring it to the human voice Research conducted at the speed of light, synthetic personas responding instantly to complex ...

Polymorphic Marketing Limited is a boutique marketing agency specialising in life science, biotechnology, laboratory consumables and scientific equipment marketing.